Summary

To summarize what we have learnt from this symposium, I will discuss the advantages and disadvantages of the use of fluoroquinolones in the treatment of respiratory tract infections. I will try to define the indications and first-line strategies for grepafloxacin use, consider some factors that have to be taken into consideration in these strategies, and describe the place of grepafloxacin versus the other quinolones